Gujarat Kidney And Super Speciality Ltd
NSE: GKSL
₹154.87
₹-4.24
(-2.66%)
As on 09-Nov-2026IST
Market cap
₹1,222 Cr
Revenue (TTM)
₹126 Cr
P/E Ratio
64.3
P/B Ratio
4.6
Div. Yield
0 %
Quality Score
7/10
Growth Score
6/10
Valuation Score
5/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹19 Cr
-
ROE
12.1 %
-
ROCE
15.5 %
-
Industry P/E
51.3
-
EV/EBITDA
35.7
-
Debt to Equity
0.1
-
Book Value
₹33.4
-
EPS
₹2.4
-
Face value
2
-
Shares outstanding
78,843,250
5 Years Aggregate
CFO
₹10.96 Cr
EBITDA
₹45.36 Cr
Net Profit
₹28.12 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Gujarat Kidney And Super Speciality
| 50.4 | -14.3 | 15.2 | -- | -- | -- | -- |
|
BSE Healthcare
| 22.2 | 9.4 | 3.6 | 19.7 | 22.8 | 16.1 | 13.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Gujarat Kidney And Super Speciality
|
154.9 | 1,221.7 | 126.2 | 20.5 | 20.6 | 7.4 | 64.3 | 4.6 |
| 537.3 | 17,037.7 | 2,363.5 | 205.5 | 14.6 | 8.1 | 98.2 | 7.6 | |
| 588.4 | 8,786.4 | 2,712.3 | 19.5 | 8.4 | 9.6 | 777.6 | 6.5 | |
| 292.2 | 9,562.8 | 1,620.7 | 186.6 | 16.0 | 12 | 51.3 | 5.9 | |
| 6,007.5 | 6,582.9 | 1,643.9 | 256.3 | 20.8 | 20.4 | 25.7 | 4.7 | |
| 749.7 | 8,131.3 | 1,606.0 | 43.8 | -- | 13 | 185.5 | 8.2 | |
| 264.1 | 11,368.4 | 1,679.4 | 273.6 | -- | 17.9 | 44 | 5.4 | |
| 1,275.2 | 12,970.1 | 1,923.4 | 298.6 | 22.3 | 17.5 | 44.4 | 7.6 | |
| 492.9 | 5,011.7 | 1,210.5 | 69.1 | -- | 11.5 | 76.8 | 6.8 | |
| 1,055.9 | 10,200.1 | 1,486.1 | 181.7 | 15.6 | 10.4 | 53.5 | 5.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Gujarat Kidney And Super Speciality
--
-
Incorporated
2019
-
Chairman
Pragnesh Yashwantsinh Bharpoda
-
Managing Director
Pragnesh Yashwantsinh Bharpoda
-
Headquarters
Vadodara, Gujarat
-
Website
Looking for more details about Gujarat Kidney And Super Speciality Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Gujarat Kidney And Super Speciality
What is the current share price of Gujarat Kidney And Super Speciality Ltd Today?
The share price of Gujarat Kidney And Super Speciality Ltd is ₹154.87 (NSE) and ₹154.95 (BSE) as of 09-Nov-2026 IST. Gujarat Kidney And Super Speciality Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Gujarat Kidney And Super Speciality Ltd?
The P/E ratio of Gujarat Kidney And Super Speciality Ltd is 64.27 times as on 09-Nov-2026, a 25 premium to its peers’ median range of 51.30 times.
The P/B ratio of Gujarat Kidney And Super Speciality Ltd is 4.63 times as on 09-Nov-2026, a 29 discount to its peers’ median range of 6.52 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
51.51 |
3.16 |
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
What is the 52 Week High and Low of Gujarat Kidney And Super Speciality Ltd?
The 52-week high and low of Gujarat Kidney And Super Speciality Ltd are Rs 209.80 and Rs 98.36 as of 10-Nov-2026.
What is the market cap of Gujarat Kidney And Super Speciality Ltd?
Gujarat Kidney And Super Speciality Ltd has a market capitalisation of ₹ 1,222 Cr as on 09-Nov-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Gujarat Kidney And Super Speciality Ltd?
Before investing in Gujarat Kidney And Super Speciality Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.